COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 2958: Articles 29571-29580  | Next

Heat treatment for reuse of disposable respirators during Covid-19 pandemic: Is filtration and fit adversely affected?
Loh, M., Clark, R., Cherrie, J. W.
10.1101/2020.04.22.20074989 — Posted: 2020-04-25
Gut microbiota may underlie the predisposition of healthy individuals to COVID-19
Gou, W., Fu, Y., Yue, L., Chen, G.-d., Cai, X., Shuai, M., Xu, F., Yi, X., Chen, H., Zhu, Y. J., Xiao, M.-l., Jiang, Z., Miao, Z., Xiao, C., Shen, B., Wu, X., Zhao, H., Ling, W., Wang, J., Chen, Y.-m., Guo, T., Zheng, J.-S.
10.1101/2020.04.22.20076091 — Posted: 2020-04-25 Discussion: Onsite | Offsite
Role of the atmospheric pollution in the Covid-19 outbreak risk in Italy
Fattorini, D., Regoli, F.
10.1101/2020.04.23.20076455 — Posted: 2020-04-25
Measuring Italian Citizens' Engagement in the First Wave of the COVID-19 Pandemic Containment Measures A Cross-sectional Study
Graffigna, G., Barello, S., Savarese, M., Palamenghi, L., Castellini, G., Bonanomi, A., Lozza, E.
10.1101/2020.04.22.20075234 — Posted: 2020-04-25
Modelling the potential impact of social distancing on the COVID-19 epidemic in South Africa
Nyabadza, F., Chirove, F., Chukwu, W. C., Visaya, M. V.
10.1101/2020.04.21.20074492 — Posted: 2020-04-25
A Library of Nucleotide Analogues Terminate RNA Synthesis Catalyzed by Polymerases of Coronaviruses Causing SARS and COVID-19
Jockusch, S., Tao, C., Li, X., Anderson, T. K., Chien, M., Kumar, S., Russo, J. J., Kirchdoerfer, R. N., Ju, J.
10.1101/2020.04.23.058776 — Posted: 2020-04-25
Insight towards the effect of the multibasic cleavage site of SARS-CoV-2 spike protein on cellular proteases
Shokeen, K., Pandey, S., Shah, M., Kumar, S.
10.1101/2020.04.25.061507 — Posted: 2020-04-25
Elevated expression of ACE2 in tumor-adjacent normal tissues of cancer patients
Winkler, T., Ben-David, U.
10.1101/2020.04.25.061200 — Posted: 2020-04-25
A rapid, low cost, and highly sensitive SARS-CoV-2 diagnostic based on whole genome sequencing
Glenn St Hilaire, B., Durand, N. C., Mitra, N., Godinez Pulido, S., Mahajan, R., Blackburn, A., Colaric, Z. L., Theisen, J. W. M., Weisz, D., Dudchenko, O., Gnirke, A., Rao, S., Kaur, P., Aiden, E. L., Aiden, A. P.
10.1101/2020.04.25.061499 — Posted: 2020-04-25
SARS-CoV-2 Productively Infects Human Gut Enterocytes
Lamers, M. M., Beumer, J., van der Vaart, J., Knoops, K., Puschhof, J., Breugem, T. I., Ravelli, R. B. G., van Schayck, J. P., Mykytyn, A. Z., Duimel, H. Q., van Donselaar, E., Riesebosch, S., Kuijpers, H. J. H., Schipper, D., van de Wetering, W. J., de Graaf, M., Koopmans, M., Cuppen, E., Peters, P. J., Haagmans, B. L., Clevers, H.
10.1101/2020.04.25.060350 — Posted: 2020-04-25 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).